Enhanced permeability branched cationic polymers, methods of making, and degradation and use in nucleic acid delivery applications
By preparing branched cationic polymers with multiple terminal groups and three-dimensional topological structures, the problem of cationic polymer carriers being unable to penetrate the skin barrier was solved, achieving efficient nucleic acid delivery and controllable degradation, which is suitable for clinical applications in gene therapy.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BINZHOU MEDICAL COLLEGE
- Filing Date
- 2026-04-17
- Publication Date
- 2026-07-10
AI Technical Summary
Existing cationic polymer carriers have difficulty penetrating the skin barrier when delivering nucleic acids, resulting in low transfection efficiency and cytotoxicity issues, which limit their application in gene therapy.
A branched cationic polymer with enhanced permeability was prepared by Michael addition reaction of small molecule amine monomers, acrylate monomers and branched small molecule organic amines. The polymer was then reacted with functionalized small molecule amine end-capping agents and finally acrylate transdermal monomers were added to form a branched cationic polymer with multiple terminal groups and a three-dimensional topological structure, which enabled controlled degradation.
Enhanced permeability branched cationic polymers exhibit excellent biocompatibility and in vivo permeability, high transfection efficiency, controllable degradation process, suitability for industrial production, and high safety of degradation products, making them suitable for clinical applications.
Smart Images

Figure CN122356471A_ABST